Full Text View
Tabular View
Study Results
Related Studies
A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars
This study has been completed.
Study NCT00825916   Information provided by Capstone Therapeutics

First Received on January 20, 2009.   Last Updated on September 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Scar Prevention
Scar Reduction
Additional conditions recognized in this trial
Cicatrix
Keloid
More general conditions related to this trial
Collagen Diseases
Connective Tissue Diseases
Fibrosis
Pathologic Processes
Interventions listed in this trial
AZX100 Drug Product
Placebo
Sponsors listed in this trial
Capstone Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services